Article: Comparison of the anti-inflammatory and analgesic effects in rats of diclofenac-sodium, felbinac and indomethacin patches

Background: Topically applied nonsteroidal anti-inflammatory drugs (NSAIDs) are used widely for the treatment of pain and inflammation in musculoskeletal disorders. This study compared the analgesic and anti-inflammatory effects of patches of 1% diclofenac-sodium, 3.5% and 0.5% felbinac and 3.75% indomethacin in rats using the carrageenan-induced paw pad edema model and the brewer's yeast-induced hyper algesia model. Two studies were conducted: in the preliminary study, the patch was removed at 2 or 24 hrs after application, and in the main study the patch was removed at 2 hrs. The volume of the right hind paw and the pain threshold were assessed at 1, 3, 5, and 7 hrs after induction of inflammation in both studies.

Results: In the main study, the edema ratio in the 1% diclofenac group at 5 hrs after induction of inflammation and the AUEC (Area Under the Effect Curve) were significantly lower than in the control animals (p=0.009). The edema suppression rate in the 1% diclofenac group (12.1-33.2%) was higher than in the 3.5% and 0.5% felbinac and 3.75% indomethacin groups. The pain threshold ratio did not decrease in the 1% diclofenac group and it was significantly higher than in the control group at 3 (p=0.0004) and 5 hrs (p=0.029). The 1/AUEC was significantly lower than that in the control group (p=0.004) and the lowest among all the NSAID groups.

Conclusions: This study demonstrated that the analgesic and anti-inflammatory effects of the 1% diclofenac sodium patch in a rat model may be exerted more promptly and persistently than with the 3.5% and 0.5% felbinac and 3.75% indomethacin patches.

Citing Articles

Needleless administration of advanced therapies into the skin via the appendages using a hypobaric patch.

Benaouda F, Inacio R, Lim C, Park H, Pitcher T, Alhnan M Proc Natl Acad Sci U S A. 2022; 119(18):e2120340119.

PMID: 35482922 PMC: 9170139. DOI: 10.1073/pnas.2120340119.

Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats.

Aganovic-Musinovic I, Burnazovic-Ristic L, Kusturica J, Kulo Cesic A, Ademovic E, Sarac-Hadzihalilovic A Saudi J Biol Sci. 2021; 28(7):3816-3822.

PMID: 34220236 PMC: 8241605. DOI: 10.1016/j.sjbs.2021.03.049.

The Role of Hydrogen Sulfide in Respiratory Diseases.

Khattak S, Zhang Q, Sarfraz M, Muhammad P, Ngowi E, Khan N Biomolecules. 2021; 11(5).

PMID: 34062820 PMC: 8147381. DOI: 10.3390/biom11050682.

Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H S donors in COVID-19 therapy.

Citi V, Martelli A, Brancaleone V, Brogi S, Gojon G, Montanaro R Br J Pharmacol. 2020; 177(21):4931-4941.

PMID: 32783196 PMC: 7436626. DOI: 10.1111/bph.15230.

Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design.

Wu M, Li C, Zhang H, Sun J, Zhu X, Li X CNS Drugs. 2020; 34(8):867-877.

PMID: 32700191 DOI: 10.1007/s40263-020-00739-z.

References

1.

Schweitzer A, Hasler-Nguyen N, Zijlstra J . Preferential uptake of the non steroid anti-inflammatory drug diclofenac into inflamed tissues after a single oral dose in rats. BMC Pharmacol. 2009; 9:5. PMC: 2661889. DOI: 10.1186/1471-2210-9-5. View

2.

Tsurumi K, Hiramatsu Y, Yamaguchi A, Hayashi M, Shibuya T . [Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 2. On subacute inflammation]. Nihon Yakurigaku Zasshi. 1973; 69(2):319-34. View

3.

Vane S . Aspirin and other anti-inflammatory drugs. Thorax. 2000; 55 Suppl 2:S3-9. PMC: 1765977. DOI: 10.1136/thorax.55.suppl_2.s3. View

4.

Collins S, Moore R, McQuay H, Wiffen P, Edwards J . Single dose oral ibuprofen and diclofenac for postoperative pain. Cochrane Database Syst Rev. 2000; (2):CD001548. DOI: 10.1002/14651858.CD001548. View

5.

Vane J . The mechanism of action of anti-inflammatory drugs. Int J Clin Pract Suppl. 2003; (135):2. View

6.

Voilley N, De Weille J, Mamet J, Lazdunski M . Nonsteroid anti-inflammatory drugs inhibit both the activity and the inflammation-induced expression of acid-sensing ion channels in nociceptors. J Neurosci. 2001; 21(20):8026-33. PMC: 6763876. View

7.

Tsurumi K, Hiramatsu Y, Nozaki M, Hayashi M, Shibuya T . [Anti-inflammatory action of N-(2,6-dichlorophenyl)-o-aminophenylacetic acid, its sodium salt, N-(2,6-dichlorophenyl)-anthranilic acid and its sodium salt. 1. On acute inflammation]. Nihon Yakurigaku Zasshi. 1973; 69(2):299-318. View

8.

Brune K . Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability. Curr Med Res Opin. 2007; 23(12):2985-95. DOI: 10.1185/030079907X242584. View

9.

Zacher J, Altman R, Bellamy N, Bruhlmann P, Da Silva J, Huskisson E . Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin. 2008; 24(4):925-50. DOI: 10.1185/030079908x273066. View

10.

Mitchell J, Warner T . Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol. 1999; 128(6):1121-32. PMC: 1571744. DOI: 10.1038/sj.bjp.0702897. View

11.

Voilley N . Acid-sensing ion channels (ASICs): new targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs). Curr Drug Targets Inflamm Allergy. 2004; 3(1):71-9. DOI: 10.2174/1568010043483980. View

Comparison of the Anti-inflammatory and Analgesic Effects in Rats of Diclofenac-sodium, Felbinac and Indomethacin Patches